Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

John Haanen

Chair of Translational Immunotherapy of Cancer

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (15)

Sahar Barjesteh van Waalwijk van Doorn

Leiden University Medical Center

NETHERLANDS

View details

Sagar Patel

Associate Professor of Medicine

University of Utah

UNITED STATES

View details

David Braun

Assistant Professor, Principal Investigator

Yale University Yale Cancer Center

UNITED STATES

View details

Marcel van Gerven

head

Radboud Universiteit Donders Institute for Brain Cognition and Behaviour

NETHERLANDS

View details

Lihua Budde

Associate Professor

City Of Hope National Medical Center

UNITED STATES

View details

Nizar M Tannir

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Allison Betof Warner

Assistant Professor, Director of Melanoma Medical Oncology, Director of Solid Tumor Cellular Therapy

Stanford University

UNITED STATES

View details

Brian Rini

Chief of Clinical Trials

Vanderbilt University Medical Center

UNITED STATES

View details

Ronald Boellaard

Head imaging methodology

VU medisch centrum

NETHERLANDS

View details

Michael Hurwitz

Associate Professor

Yale University School of Medicine

UNITED STATES

View details

Benoit Beuselinck

Prof Dr

KU Leuven

BELGIUM

View details

Saskia de Groot

NETHERLANDS

View details

Jason J. Luke

UNITED STATES

View details

Hedwig Blommestein

Associate professor

Erasmus University Rotterdam

NETHERLANDS

View details

Giao Phan

University of Connecticut Health Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Haanen

Research Interests

Explore related searches

Articles (20)

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles

Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review

Publisher Correction: Clinical development of cancer vaccines

Clinical development of cancer vaccines

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data

Multimodal integration of longitudinal noninvasive diagnostics for survival prediction in immunotherapy using deep learning

Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma

Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better?

Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors

Imaging Proliferation of Stage IV Cutaneous Melanoma With 18F-FLT PET/CT

Treatment of patients with pMMR GI cancers with tumor-infiltrating lymphocytes (TIL): a reality?

CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma

Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma

Baseline and on Treatment Biodistribution Variability of 18F-FLT Uptake in Patients With Advanced Melanoma: Brief Communication

Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol

Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis

Melanoma neoantigen vaccines: Are we getting more personal now?

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma

Collaborators (15)

Sahar Barjesteh van Waalwijk van Doorn

Sagar Patel

David Braun

Marcel van Gerven

Lihua Budde

Nizar M Tannir

Allison Betof Warner

Brian Rini

Ronald Boellaard

Michael Hurwitz

Benoit Beuselinck

Saskia de Groot

Jason J. Luke

Hedwig Blommestein

Giao Phan

Make your next move.